Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Wang, Lin  [Clear All Filters]
Journal Article
Zhang H, Rodriguez S, Wang L, Wang S, Serezani H, Kapur R, Cardoso AA, Carlesso N. Sepsis Induces Hematopoietic Stem Cell Exhaustion and Myelosuppression through Distinct Contributions of TRIF and MYD88. Stem Cell Reports. 2016.
Xu X, Wang L, Hu L, Dirks WG, Zhao Y, Wei Z, Chen D, Li Z, Wang Z, Han Y, et al. Small Molecular Modulators of JMJD1C Preferentially Inhibit Growth of Leukemia Cells. Int J Cancer. 2019.
Wang Y, Zhu G, Li N, Song J, Wang L, Shi X. Small molecules and their controlled release that induce the osteogenic/chondrogenic commitment of stem cells. Biotechnol Adv. 2015.
Li X, Qi M, Sun X, Weir MD, Tay FR, Oates TW, Dong B, Zhou Y, Wang L, Xu HHK. Surface treatments on titanium implants via nanostructured ceria for antibacterial and anti-inflammatory capabilitiess. Acta Biomater. 2019.
Cheng J, Zeng D, Zhang T, Zhang L, Han X, Zhou P, Wang L, He J, Han Q. SZ 2021: A potentially new genotype of , which can cause fatal pulmonary infection in patients with acute leukemia following haplo‑HSCT. Exp Ther Med. 2023;26(2):404.
Zhang W, Tang M, Wang L, Zhou H, Gao J, Chen Z, Zhao B, Zheng P. -TRIM28-HSP90B1 complex on replication forks promotes CMG helicase retention to ensure stem cell genomic stability and embryogenesis. Sci Adv. 2023;9(4):eadf6277.
Wang N, Guo D, Zhao YY, Dong CY, Liu X, Yang BX, Wang SW, Wang L, Liu QG, Ren Q, et al. TWIST-1 promotes cell growth, drug resistance and progenitor clonogenic capacities in myeloid leukemia and is a novel poor prognostic factor in acute myeloid leukemia. Oncotarget. 2015.
Gong X, He X, Wang L, Yu T, Liu W, Xu H, Jin L, Li X, Zhang B, Tao Z, et al. Venetoclax-based therapy for relapsed or refractory acute myeloid leukemia: latest updates from the 2023 ASH annual meeting. Exp Hematol Oncol. 2024;13(1):17.
Gong X, Zhang Y, He X, Moloudizargari M, Yu T, Wang L, Liu W, Jin L, Xu H, Xu Y, et al. Venetoclax-based therapy for relapsed or refractory acute myeloid leukemia: latest updates from the 2022 ASH annual meeting. Exp Hematol Oncol. 2023;12(1):57.

Pages